CREMα is implicated in immune disorders such as Systemic Lupus Erythematosus (SLE), where its expression is enhanced by transcription factor SP1 and histone lysine methyltransferase SET1 binding to the Crem P1 promoter. The gene discussed is SETD1A; the disease is systemic lupus erythematosus.